Phone-based therapy beneficial for depression in Parkinson’s disease … Sending COVID-19-positive residents to hospital may be wrong ‘knee-jerk’ reaction … CDC releases COVID-19 infection prevention and control recommendations for healthcare settings … Lifestyle changes could delay memory decline – depending on our genes
At-risk staff offered a place to stay at Affinity facilities during COVID-19 outbreak … Study details the first known US person-to-person coronavirus transmission … Senators to introduce bill addressing medical supply vulnerability due to coronavirus … ‘Natural killer’ cells could halt Parkinson’s progression … Streaming senior-fitness video vendor publicizing free trial during COVID-19 outbreak
Parkinson’s patients carry a heavy burden of eye disease, but treatment can help improve daily function, say researchers.
Surgery with anesthesia not linked to Alzheimer’s, study finds … Guidance released for dialysis facilities during COVID-19 outbreak … New book details roadmap to prevent and treat Parkinson’s … Cancer death rates continue to decline: CDC
Participants in a non-contact boxing program reported improved non-motor symptoms and greater confidence in their ability to continue exercising.
Motor symptoms and functional abilities improved when seniors engaged in weekly ping pong sessions designed by experienced players.
A study of long-distance skiers showed that physical fitness may delay clinical symptoms for years.
Ageism linked to health problems in the elderly … Study confirms diabetes drug’s link to heart problems … Simple blood test could help predict progression of Parkinson’s … EEG identifies who will respond to antidepressant
Palliative care surpasses standard care for improving quality of life and motor symptoms in people with Parkinson’s disease, say researchers.
‘Ageotypes’ study ties healthy behaviors to decrease in aging markers … Access to Medicare increases cancer detection, reduces cancer mortality rate … Psychiatric conditions linked to cognitive performance in Parkinson’s … Eli Lilly to launch half-priced versions of two more insulin products
